Viruses as Quasispecies: Biological Implications

  • E. Domingo
  • V. Martín
  • C. Perales
  • A. Grande-Pérez
  • J. García-Arriaza
  • A. Arias
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 299)


During viral infections, the complex and dynamic distributions of variants, termed viral quasispecies, play a key role in the adaptability of viruses to changing environments and the fate of the population as a whole. Mutant spectra are continuously and avoidably generated during RNA genome replication, and they are not just a by-product of error-prone replication, devoid of biological relevance. On the contrary, current evidence indicates that mutant spectra contribute to viral pathogenesis, can modulate the expression of phenotypic traits by subpopulations of viruses, can include memory genomes that reflect the past evolutionary history of the viral lineage, and, furthermore, can participate in viral extinction through lethal mutagenesis. Also, mutant spectra are the target on which selection and random drift act to shape the long-term evolution of viruses. The biological relevance of mutant spectra is the central topic of this chapter.


Vesicular Stomatitis Virus Mutant Spectrum Biological Implication Lymphocytic Choriomeningitis Virus Mutant Distribution 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Agol VI (2002) Picornavirus genetics: an overview. In Semler BL, Wimmer E (eds) Molecular biology of picornaviruses. American Society for Microbiology, Washington DC, pp 269–284Google Scholar
  2. Airaksinen A, Pariente N, Menendez-Arias L, Domingo E (2003) Curing of foot-and-mouth disease virus from persistently infected cellsby ribavirin involves enhanced mutagenesis. Virology 311:339–349CrossRefPubMedGoogle Scholar
  3. Anderson JP, Daifuku R, Loeb LA (2004) Viral error catastrophe by mutagenic nucleosides. Annu Rev Microbiol 58:183–205CrossRefPubMedGoogle Scholar
  4. Arias A, Agudo R, Ferrer-Orta C, Pérez-Luque R, Airaksinen A, Brocchi E, Domingo E, Verdaguer N, Escarmis C (2005) Mutant viral polymerase in the transition of virus to error catastrophe identifies a critical site for RNA binding. J Mol Biol (in press)Google Scholar
  5. Arias A, Lázaro E, Escarmís C, Domingo E (2001) Molecular intermediates of fitness gain of an RNA virus: characterization of a mutant spectrum by biological and molecular cloning. J Gen Virol 82:1049–1060PubMedGoogle Scholar
  6. Arias A, Ruiz-Jarabo CM, Escarmis C, Domingo E (2004) Fitness increase of memory genomes in a viral quasispecies. J Mol Biol 339:405–412CrossRefPubMedGoogle Scholar
  7. Baranowski E, Ruíz-Jarabo CM, Pariente N, Verdaguer N, Domingo E (2003) Evolution of cell recognition by viruses: a source of biological novelty with medical implications. Adv Virus Res 62:19–111PubMedGoogle Scholar
  8. Bergstrom CT, McElhany P, Real LA (1999) Transmission bottlenecks as determinants of virulence in rapidly evolving pathogens. Proc Natl Acad Sci U S A 96:5095–5100PubMedGoogle Scholar
  9. Biebricher CK (1999) Mutation, competition and selection as measured with small RNA molecules. In Domingo E, Webster RG, Holland JJ (eds) Origin and evolution of viruses. Academic Press, San Diego, pp 65–85Google Scholar
  10. Borrego B, Novella IS, Giralt E, Andreu D, Domingo E (1993) Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection. J Virol 67:6071–6079PubMedGoogle Scholar
  11. Borrow P, Lewicki H, Wei X, Horwitz MS, Peffer N, Meyers H, Nelson JA, Gairin JE, Hahn BH, Oldstone MB, Shaw GM (1997) Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med 3:205–211CrossRefPubMedGoogle Scholar
  12. Briones C, Mas A, Gómez-Mariano G, Altisent C, Menéndez-Arias L, Soriano V, Domingo E (2000) Dynamics of dominance of a dipeptide insertion in reverse transcriptase of HIV-1 from patients subjected to prolonged therapy. Virus Res 66:13–26CrossRefPubMedGoogle Scholar
  13. Briones C, Domingo E, Molina-París C (2003) Memory in retroviral quasispecies: experimental evidence and theoretical model for human immunodeficiency virus. J Mol Biol 331:213–229CrossRefPubMedGoogle Scholar
  14. Charpentier C, Dwyer DE, Mammano F, Lecossier D, Clavel F, Hance AJ (2004) Role of minority populations of human immunodeficiency virus type 1 in the evolution of viral resistance to protease inhibitors. J Virol 78:4234–4247CrossRefPubMedGoogle Scholar
  15. Chumakov KM, Powers LB, Noonan KE, Roninson IB, Levenbook IS (1991) Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine. Proc Natl Acad Sci U S A 88:199–203PubMedGoogle Scholar
  16. Coffin JM (1995) HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267:483–489PubMedGoogle Scholar
  17. Condit C (2001) Principles of virology. In Knipe DM, Howley PM (eds) Fields virology. Lippincot Williams and Wilkins, Philadelphia, pp 811–815Google Scholar
  18. Contreras AM, Hiasa Y, He W, Terella A, Schmidt EV, Chung RT (2002) Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system. J Virol 76:8505–8517CrossRefPubMedGoogle Scholar
  19. Cornell CT, Brunner JE, Semler BL (2004) Differential rescue of poliovirus RNA replication functions by genetically modified RNA polymerase precursors. J Virol 78:13007–13018PubMedGoogle Scholar
  20. Cowan GA, Pines D, Meltzer D (eds) (1994) Complexity. Metaphors, models and reality. The Advanced Book Program, Jacob Way. Addison-Wesley Publishing, Reading, MAGoogle Scholar
  21. Crotty S, Maag D, Arnold JJ, Zhong W, Lau JYN, Hong Z, Andino R, Cameron CE (2000) The broad-spectrum antiviral ribonucleotide, ribavirin, is an RNA virus mutagen. Nat Med 6:1375–1379PubMedGoogle Scholar
  22. De la Torre JC, Holland JJ (1990) RNA virus quasispecies populations can suppress vastly superior mutant progeny. J Virol 64:6278–6281PubMedGoogle Scholar
  23. Crotty S, Cameron CE, Andino R (2001) RNA virus error catastrophe: direct molecular test by using ribavirin. Proc Natl Acad Sci U S A 98:6895–6900CrossRefPubMedGoogle Scholar
  24. DeFilippis VR, Villarreal LP (2000) An introduction to the evolutionary ecology of viruses. In Hurst CJ (ed) Viral ecology. Academic Press, San Diego, pp 125–208Google Scholar
  25. Dobzhansky T (1973) Nothing in biology makes sense except in the light of evolution. Am Biol Teacher 35:125–129Google Scholar
  26. Domingo E (1996) Biological significance of viral quasispecies. Viral Hepatitis Reviews 2:247–261Google Scholar
  27. Domingo E (1997) RNA virus evolution, population dynamics, and nutritional status. Biol Trace Elem Res 56:23–30PubMedGoogle Scholar
  28. Domingo E (1999) Quasispecies. In Granoff A, Webster RG (eds) Encyclopedia of virology. Academic Press, London, pp 1431–1436Google Scholar
  29. Domingo E (2000) Viruses at the edge of adaptation. Virology 270:251–253CrossRefPubMedGoogle Scholar
  30. Domingo E (2003) Quasispecies and the development of new antiviral strategies. Prog Drug Res 60:133–158PubMedGoogle Scholar
  31. Domingo E (2005a) Microbial evolution and emerging diseases. In Power C, Johnson RT (eds) Emerging neurological infections. Marcel Dekker, New YorkGoogle Scholar
  32. Domingo E (2005b) Virus entry into error catastrophe as a new antiviral strategy. 107:115–228Google Scholar
  33. Domingo E, Holland JJ (1997) RNA virus mutations and fitness for survival. Annu Rev Microbiol 51:151–178CrossRefPubMedGoogle Scholar
  34. Domingo E, Holland JJ, Biebricher C, Eigen M (1995) Quasispecies: the concept and the word. In Gibbs A, Calisher C, García-Arenal F (eds) Molecular evolution of the viruses. Cambridge University Press, Cambridge, pp 171–180Google Scholar
  35. Domingo E, Biebricher C, Eigen M, Holland JJ (2001) Quasispecies and RNA virus evolution: principles and consequences. Austin, Landes BioscienceGoogle Scholar
  36. Domingo E, Ruíz-Jarabo CM, Arias A, Molina-Paris C, Briones C, Baranowski E, Escarmís C (2003) Detection and biological implications of genetic memory in viral quasispecies. In Matsumori A (ed) Cardiomyopathies and heart failure: biomolecular, infectious and immune mechanisms. Kluwer, London, pp 259–276Google Scholar
  37. Domingo E, Brun A, Núñez JI, Cristina J, Briones C, Escarmís C ((2006) Genomics of viruses. In Hacker J, Dobrindt U (eds) Pathogenomics: Genome Analysis of Pathogenic Microbes. WILEY-VCH Verlag GmbH and Co.KGaA, Weinheim, 369–388Google Scholar
  38. Drake JW, Holland JJ (1999) Mutation rates among RNA viruses. Proc Natl Acad Sci U S A 96:13910–13913CrossRefPubMedGoogle Scholar
  39. Eastman PS, Blair CD (1985) Temperature-sensitive mutants of Japanese encephalitis virus. J Virol 55:611–616PubMedGoogle Scholar
  40. Eigen M (1971) Self-organization of matter and the evolution of biological macromolecules. Naturwissenschaften 58:465–523CrossRefPubMedGoogle Scholar
  41. Eigen M (1992) Steps towards life. Oxford University Press, OxfordGoogle Scholar
  42. Eigen M (2002) Error catastrophe and antiviral strategy. Proc Natl Acad Sci U S A 99:13374–13376CrossRefPubMedGoogle Scholar
  43. Eigen M, Schuster P (1979) The hypercycle. A principle of natural self-organization. Springer, Berlin Heidelberg New YorkGoogle Scholar
  44. Eigen M, Biebricher CK (1988) Sequence space and quasispecies distribution. In Domingo E, Ahlquist P Holland JJ (eds) RNA genetics. CRC Press, Boca Raton, FL, pp 211–245Google Scholar
  45. Escarmís C, Dávila M, Charpentier N, Bracho A, Moya A, Domingo E (1996) Genetic lesions associated with Muller’s ratchet in an RNA virus. J Mol Biol 264:255–267CrossRefPubMedGoogle Scholar
  46. Flint SJ, Enquist LW, Racaniello VR, Skalka AM (2004) Principles of virology. Molecular biology, pathogenesis, and control of animal viruses. ASMPress, Washington, DCGoogle Scholar
  47. Frank SA (1996) The design of natural and artificial adaptive systems. In Rose MR, Lauder GV (eds) Adaptation. Academic, San Diego, pp 451–505Google Scholar
  48. Freistadt MS, Meades GD, Cameron CE (2004) Lethal mutagens: broad-spectrum antivirals with limited potential for development of resistance? Drug Resist Updat 7:19–24PubMedGoogle Scholar
  49. García-Lerma JG, Nidtha S, Blumoff K, Weinstock H, Heneine W (2001) Increased ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons. Proc Natl Acad Sci U S A 98:13907–13912PubMedGoogle Scholar
  50. García-Arriaza J, Manrubia SC, Toja M, Domingo E, Escarmís C (2004) Evolutionary transition toward defective RNAs that are infectious by complementation. J Virol 78:11678–11685PubMedGoogle Scholar
  51. García-Arriaza J, Domingo E, Escarmís C (2005) A segmented form of foot-and-mouth disease virus interferes with standard virus: a link between interference and competitive fitness. Virology 335:155–164PubMedGoogle Scholar
  52. Gell-Mann M (1994) Complex adaptive systems. In Cowan GA, Pines D Meltzer D (eds) Complexity metaphors, models and reality. Wesley, Reading, MA, pp 17–45Google Scholar
  53. Gerrish PJ, Garcia-Lerma JG (2003) Mutation rate and the efficacy of antimicrobial drug treatment. The Lancet Infect Dis 3:28–32Google Scholar
  54. González-López C, Gómez-Mariano G, Escarmís C, Domingo E (2005) Invariant aphthovirus consensus nucleotide sequence in the transition to error catastrophe. Infect Genet Evol 5:366–374PubMedGoogle Scholar
  55. González-López C, Arias A, Pariente N, Gómez-Mariano G, Domingo E (2004) Preextinction viral RNA can interfere with infectivity. J Virol 78:3319–3324PubMedGoogle Scholar
  56. Graci JD, Cameron CE (2002) Quasispecies, error catastrophe, and the antiviral activity of ribavirin. Virology 298:175–180CrossRefPubMedGoogle Scholar
  57. Grande-Pérez A, Sierra S, Castro MG, Domingo E, Lowenstein PR (2002) Molecular indetermination in the transition to error catastrophe: systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexity. Proc Natl Acad Sci U S A 99:12938–12943PubMedGoogle Scholar
  58. Grande-Pérez A, Lázaro E, Lowenstein P, Domingo E, Manrubia SC (2005) Suppression of viral infectivity through lethal defection. Proc Natl Acad Sci U S A 102:4448–4452PubMedGoogle Scholar
  59. Grande-Pérez A, Gómez-Mariano G, Lowenstein P, Domingo E (2005) Mutagenesis-induced, large fitness variations with an invariant arenavirus consensus genomic nucleotide sequence. J Virol 79:10451–10459PubMedGoogle Scholar
  60. Holland JJ (1990) Defective viral genomes. In Fields BM, Knipe DM (eds) Virology. Raven, New York, pp 151–165Google Scholar
  61. Holland JJ, Domingo E, de la Torre JC, Steinhauer DA (1990) Mutation frequencies at defined single codon sites in vesicular stomatitis virus and poliovirus can be increased only slightly by chemical mutagenesis. J Virol 64:3960–3962PubMedGoogle Scholar
  62. Holland JJ, de la Torre JC, Clarke DK, Duarte E (1991) Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses. J Virol 65:2960–2967PubMedGoogle Scholar
  63. Huang AS, Baltimore D (1970) Defective viral particles and viral disease processes. Nature 226:325–327CrossRefPubMedGoogle Scholar
  64. Imamichi H, Crandall KA, Natarajan V, Jiang MK, Dewar RL, Berg S, Gaddam A, Bosche M, Metcalf JA, Davey RT Jr, Lane HC (2001) Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapy. J Infect Dis 183:36–50CrossRefPubMedGoogle Scholar
  65. Karlsson AC, Gaines H, Sallberg M, Lindback S, Sonnerborg A (1999) Reappearance of founder virus sequence in human immunodeficiency virus type 1-infected patients. J Virol 73:6191–6196PubMedGoogle Scholar
  66. Kijak GH, Simon V, Balfe P, Vanderhoeven J, Pampuro SE, Zala C, Ochoa C, Cahn P, Markowitz M, Salomon H (2002) Origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failure. J Virol 76:7000–7009CrossRefPubMedGoogle Scholar
  67. Lanford RE, Chavez D, Guerra B, Lau JY, Hong Z, Brasky KM, Beames B (2001) Ribavirin induces error-prone replication of GB virus B in primary tamarin hepatocytes. J Virol 75:8074–8081CrossRefPubMedGoogle Scholar
  68. Lau DT, Khokhar MF, Doo E, Ghany MG, Herion D, Park Y, Kleiner DE, Schmid P, Condreay LD, Gauthier J, Kuhns MC, Liang TJ, Hoofnagle JH (2000) Long-term therapy of chronic hepatitis B with lamivudine. Hepatology 32:828–834PubMedGoogle Scholar
  69. Lee CH, Gilbertson DL, Novella IS, Huerta R, Domingo E, Holland JJ (1997) Negative effects of chemical mutagenesis on the adaptive behavior of vesicular stomatitis virus. J Virol 71:3636–3640PubMedGoogle Scholar
  70. Lewontin RC (1970) The units of selection. Annu Rev Ecol System 1:1–18Google Scholar
  71. Loeb LA, Mullins JI (2000) Lethal mutagenesis of HIV by mutagenic ribonucleoside analogs. AIDS Res Hum Retroviruses 13:1–3Google Scholar
  72. Loeb LA, Essigmann JM, Kazazi F, Zhang J, Rose KD, Mullins JI (1999) Lethal mutagenesis of HIV with mutagenic nucleoside analogs. Proc Natl Acad Sci U S A 96:1492–1497CrossRefPubMedGoogle Scholar
  73. Maag D, Castro C, Hong Z, Cameron CE (2001) Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as amediator of the antiviral activity of ribavirin. J Biol Chem 276:46094–46098CrossRefPubMedGoogle Scholar
  74. Mahy BWJ (ed) (2005) Foot-and-mouth disease virus. Curr Topics Microbiol Immunol 288Google Scholar
  75. McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK (1998) Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 339:1485–1492CrossRefPubMedGoogle Scholar
  76. Miralles R, Gerrish PJ, Moya A, Elena SF (1999) Clonal interference and the evolution of RNA viruses. Science 285:1745–1747CrossRefPubMedGoogle Scholar
  77. Moreno IM, Malpica JM, Rodriguez-Cerezo E, Garcia-Arenal F (1997) A mutation in tomato aspermy cucumovirus that abolishes cell-to-cell movement is maintained to high levels in the viral RNA population by complementation. J Virol 71:9157–9162PubMedGoogle Scholar
  78. Mount DW (2004) Bioinformatics. sequence and genome analysis. Cold Spring Harbor Laboratory Press, Cold Spring HarborGoogle Scholar
  79. Nájera I, Holguín A, Quiñones-Mateu ME, Muñoz-Fernández MA, Nájera R, López-Galíndez C, Domingo E (1995) Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy. J Virol 69:23–3PubMedGoogle Scholar
  80. Novella IS (2003) Contributions of vesicular stomatitis virus to the understanding of RNA virus evolution. Curr Opin Microbiol 6:399–405CrossRefPubMedGoogle Scholar
  81. Novella IS (2004) Negative effect of genetic bottlenecks on the adaptability of vesicular stomatitis virus. J Mol Biol 336:61–67CrossRefPubMedGoogle Scholar
  82. Novella IS, Elena SF, Moya A, Domingo E, Holland JJ (1995) Size of genetic bottlenecks leading to virus fitness loss is determined by mean initial population fitness. J Virol 69:2869–2872PubMedGoogle Scholar
  83. Novella IS, Quer J, Domingo E, Holland JJ (1999) Exponential fitness gains of RNA virus populations are limited by bottleneck effects. J Virol 73:1668–1671PubMedGoogle Scholar
  84. Novella IS, Reissig DD, Wilke CO (2004) Density-dependent selection in vesicular stomatitis virus. J Virol 78:5799–5804PubMedGoogle Scholar
  85. Nowak M, Schuster P (1989) Error thresholds of replication in finite populations mutation frequencies and the onset of Muller’s ratchet. J Theor Biol 137:375–395PubMedGoogle Scholar
  86. Nowak MA, May RM (2000) Virus dynamics. Mathematical principles of immunology and virology. Oxford University Press, New YorkGoogle Scholar
  87. Oldstone MBA (2002) Biology and pathogenesis of lymphocytic choriomeningitis virus infection. Curr Top Microbiol Immunol 263:83–117PubMedGoogle Scholar
  88. Pariente N, Sierra S, Lowenstein PR, Domingo E (2001) Efficient virus extinction by combinations of a mutagen and antiviral inhibitors. J Virol 75:9723–9730CrossRefPubMedGoogle Scholar
  89. Parker WB, Cheng YC (1990) Metabolism and mechanism of action of 5-fluorouracil. Pharmacol Ther 48:381–395CrossRefPubMedGoogle Scholar
  90. Perales C, Martin V, Ruiz-Jarabo CM, Domingo E (2005) Monitoring sequence space as a test for the target of selection in viruses. J Mol Biol 345:451–459CrossRefPubMedGoogle Scholar
  91. Perrault J (1981) Origin and replication of defective interfering particles. Curr Top Microbiol Immunol 93:151–207PubMedGoogle Scholar
  92. Pringle CR (1970) Genetic characteristics of conditional lethal mutants of vesicular stomatitis virus induced by 5-fluorouracil, 5-azacytidine, and ethyl methane sulfonate. J Virol 5:559–567PubMedGoogle Scholar
  93. Quiñones-Mateu ME, Arts EJ (2002) HIV-1 fitness: implications for drug resistance, disease progression, and global epidemic evolution. In Theoretical Biology and Biophysics Group. Kuiken C, Foley B, Hahn BH, Marx P, McCutchan FE, Mellors J, Mullins JI, Sodroski J, Wolinsky S Korber BT (eds) HIV-1 sequence compendium. Los Alamos National Laboratory, Los Alamos NM, pp 134–170Google Scholar
  94. Ribeiro RM, Bonhoeffer S, Nowak MA (1998) The frequency of resistant mutant virus before antiviral therapy. AIDS 26:461–465Google Scholar
  95. Rowlands DJ (ed) (2003) Foot-and-mouth disease. Virus Res 91:1–161Google Scholar
  96. Ruiz-Jarabo CM, Arias A, Baranowski E, Escarmís C, Domingo E (2000) Memory in viral quasispecies. J Virol 74:3543–3547CrossRefPubMedGoogle Scholar
  97. Ruiz-Jarabo CM, Arias A, Molina-París C, Briones C, Baranowski E, Escarmís C, Domingo E (2002) Duration and fitness dependence of quasispecies memory. J Mol Biol 315:285–296PubMedGoogle Scholar
  98. Ruiz-Jarabo CM, Ly C, Domingo E, de la Torre JC (2003a) Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV). Virology 308:37–47CrossRefPubMedGoogle Scholar
  99. Ruiz-Jarabo CM, Miller E, Gómez-Mariano G, Domingo E (2003b) Synchronous loss of quasispecies memory in parallel viral lineages: a deterministic feature of viral quasispecies. J Mol Biol 333:553–563CrossRefPubMedGoogle Scholar
  100. Severson WE, Schmaljohn CS, Javadian A, Jonsson CB (2003) Ribavirin causes error catastrophe during Hantaan virus replication. J Virol 77:481–488PubMedGoogle Scholar
  101. Sierra S, Dávila M, Lowenstein PR, Domingo E (2000) Response of foot-and-mouth disease virus to increased mutagenesis. Influence of viral load and fitness in loss of infectivity. J Virol 74:8316–8323CrossRefPubMedGoogle Scholar
  102. Simmonds P, Smith DB (1999) Structural constraints on RNA virus evolution. J Virol 73:5787–5794PubMedGoogle Scholar
  103. Simmonds P, Tuplin A, Evans DJ (2004) Detection of genome-scale ordered RNA structure (GORS) in genomes of positive-stranded RNA viruses: implications for virus evolution and host persistence. RNA 10:1337–1351CrossRefPubMedGoogle Scholar
  104. Smolinski MS, Hamburg MA, Lederberg J (eds) (2003) Microbial threats to health. Emergence, detection and response. The National Academies Press, Washington, DCGoogle Scholar
  105. Snell NJ (2001) Ribavirin—current status of a broad spectrum antiviral agent. Expert Opin Pharmacother 2:1317–1324CrossRefPubMedGoogle Scholar
  106. Snijder EJ, Bredenbeek PJ, Dobbe JC, Thiel V, Ziebuhr J, Poon LL, Guan Y, Rozanov M, Spaan WJ, Gorbalenya AE (2003) Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol 331:991–1004CrossRefPubMedGoogle Scholar
  107. Sobrino F, Domingo E (eds) (2004) Foot-and-mouth disease: current perspectives. Horizon Bioscience. Wymondham, UKGoogle Scholar
  108. Solé R, Goodwin B (2000) Signs of life. how complexity pervedes biology. Basic Books, New YorkGoogle Scholar
  109. Swetina J, Schuster P (1982) Self-replication with errors. A model for polynucleotide replication. Biophys Chem 16:329–345CrossRefPubMedGoogle Scholar
  110. Teng MN, Oldstone MB, de la Torre JC (1996) Suppression of lymphocytic choriomeningitis virus-induced growth hormone deficiency syndrome by diseasenegative virus variants. Virology 223:113–119CrossRefPubMedGoogle Scholar
  111. Turner PE, Chao L (1998) Sex and the evolution of intrahost competition in RNA virus phi6. Genetics 150:523–532PubMedGoogle Scholar
  112. Vo NV, Young KC, Lai MMC (2003) Mutagenic and inhibitory effects of ribavirin on hepatitis C virus RNA polymerase. Biochemistry 42:10462–10471PubMedGoogle Scholar
  113. Volkenstein MV (1994) Physical approaches to biological evolution. Springer-Verlag, Berlin Heidelberg New YorkGoogle Scholar
  114. Welsh C (2003) Antibiotics. Actions, origins, resistance. ASM Press, Washington, DCGoogle Scholar
  115. White DO, Fenner FJ (1986) Medical virology. Academic, Orlando, FLGoogle Scholar
  116. Wilke CO, Reissig DD, Novella IS (2004) Replication at periodically changing multiplicity of infection promotes stable coexistence of competing viral populations. Evolution Int J Org Evolution 58:900–905PubMedGoogle Scholar
  117. Williams GC (1992) Natural selection. Domains, levels and challenges. Oxford University Press, New YorkGoogle Scholar
  118. Woese CR (2004) A new biology for a new century. Microbiol Mol Biol Reviews 68:173–186Google Scholar
  119. Woolhouse MEJ (2004) Mathematical models of the epidemiology and control of foot-and-mouth disease. In Sobrino F, Domingo E (eds) Foot and mouth disease current perspectives. Horizon Bioscience, Wymondham UK, pp 355–381Google Scholar
  120. Wyatt CA, Andrus L, Brotman B, Huang F, Lee DH, Prince AM (1998) Immunity in chimpanzees chronically infected with hepatitis C virus: role of minor quasispecies in reinfection. J Virol 72:1725–1730PubMedGoogle Scholar
  121. Youngner JS, Whitaker-Dowling P (1999) Interference. In Granoff A, Webster RG (eds) Encyclopedia of virology. Academic Press, San Diego, pp 850–854Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2006

Authors and Affiliations

  • E. Domingo
    • 1
  • V. Martín
    • 1
  • C. Perales
    • 1
  • A. Grande-Pérez
    • 1
  • J. García-Arriaza
    • 1
  • A. Arias
    • 1
  1. 1.Centro de Biología Molecular “Severo Ochoa” (CSIC-UAM)Universidad Autónoma de MadridCantoblanco, MadridSpain

Personalised recommendations